← Today’s ReceiptsSource pending
Public-record receiptR-NCSource pending
Tim Moore disclosed BUY $AAL
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2025-04-14
Trade date
2025-03-14
Disclosure lag
31 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 31 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
422 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Tim Moore, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 25 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-04-14 · disclosed 31d after transaction
Market context
American Airlines Group Inc.
Sector: Industrials
Vs SPY: 17.0%
Factual flags
- 25 lobbying filings linked to this ticker.
- 22 nearby same-ticker disclosures in the surrounding 30-day window.
- 23 committee-overlap trades landed within 30 days in the defense,aerospace sector; treat this as a public-record clustering signal only.
- AAL transaction date was 18d before a public lobbying filing by AMERICAN AIRLINES INC ($50,000); committee-sector context: Financials; this is timing context, not a finding of intent.
- Committee coverage overlaps the defense/aerospace sector for AAL; this is contextual public-record overlap, not a finding of intent.
Member trail
Ticker trail
$AAL
American Airlines Group Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.